about
Regulation of the apolipoprotein gene cluster by a long noncoding RNAInduction of paraoxonase 1 and apolipoprotein A-I gene expression by aspirinStructure and dynamic properties of membrane proteins using NMR.High density lipoprotein 3 inhibits oxidized low density lipoprotein-induced apoptosis via promoting cholesterol efflux in RAW264.7 cells.A gene score of nine LDL and HDL regulating genes is associated with fluvastatin-induced cholesterol changes in womenRetinoid-related Orphan Receptors (RORs): Roles in Cellular Differentiation and Development.Increased disease activity is associated with a deteriorated lipid profile in patients with ankylosing spondylitisApolipoprotein A-II-mediated conformational changes of apolipoprotein A-I in discoidal high density lipoproteins.31st g. Heiner sell lectureship: secondary medical consequences of spinal cord injury.Dysfunctional HDL containing L159R ApoA-I leads to exacerbation of atherosclerosis in hyperlipidemic mice.Coronary heart disease in individuals with spinal cord injury: assessment of risk factors.Discrete roles of apoA-I and apoE in the biogenesis of HDL species: lessons learned from gene transfer studies in different mouse models.Water-Soluble Components of Sesame Oil Reduce Inflammation and Atherosclerosis.Açai (Euterpe oleracea Mart.) Upregulates Paraoxonase 1 Gene Expression and Activity with Concomitant Reduction of Hepatic Steatosis in High-Fat Diet-Fed Rats.Apolipoprotein B but not LDL cholesterol is associated with coronary artery calcification in type 2 diabetic whites.Residues Leu261, Trp264, and Phe265 account for apolipoprotein E-induced dyslipidemia and affect the formation of apolipoprotein E-containing high-density lipoprotein.The effect of nutritional supplements on serum high-density lipoprotein cholesterol and apolipoprotein A-I.Regulation of apoA-I gene expression: mechanism of action of estrogen and genistein.Peroxisome proliferator-activated receptor-α activation promotes macrophage reverse cholesterol transport through a liver X receptor-dependent pathway.Sphingomyelin synthase overexpression increases cholesterol accumulation and decreases cholesterol secretion in liver cells.Components of Boiogito Suppress the Progression of Hypercholesterolemia and Fatty Liver Induced by High-Cholesterol Diet in Rats.Effect of Daisaikoto on Expressions of SIRT1 and NF-kappaB of Diabetic Fatty Liver Rats Induced by High-Fat Diet and Streptozotocin.Is regression of coronary atherosclerosis possible by infusing recombinant apolipoprotein A-I?Pathway of biogenesis of apolipoprotein E-containing HDL in vivo with the participation of ABCA1 and LCAT.A glimpse at HDL-based therapy for atherosclerosisThe influence of visceral fat on the postprandial lipemic response in men with paraplegia.The prevalence of dyslipoproteinemia in Thai patients with systemic lupus erythematosus.Relevance of the amino acid conversions L144R (Zaragoza) and L159P (Zavalla) in the apolipoprotein A-I binding site for haptoglobin.Genetic determinants of plasma HDL-cholesterol levels in familial hypercholesterolemia.Natural antisense transcripts in diseases: From modes of action to targeted therapies.
P2860
Q28305168-A287F132-E82D-4D2F-806E-BBDAB6A467C4Q28570302-D07C7758-C26F-42F0-9A78-10D255E7DDE8Q30432371-A6020C01-C423-40CF-89F4-D2D6AAE310FBQ33231598-AC0E38C8-0D26-431E-8B5C-4DFF490E7AD1Q33634188-2E1CD2A9-F317-42B4-BCB5-41E0AF0D67BDQ34770626-47AB113B-C25B-4043-AA4B-1CECB9DB8F10Q35638180-A45267F3-7834-4F21-9D08-BD53A7448931Q35802050-B282DE70-8DE3-4BB0-980F-80C11871ED83Q36646317-7606BBBC-8438-49ED-8FBB-77543F36634BQ36948639-A77F20C0-3672-4719-A0D7-0F2D93D344C6Q37052621-3D5D3408-4AA4-4F90-AC1C-EB4B78FC0D7EQ37076007-ABF2755B-F3AB-4E7D-826C-43B91D71F867Q37102203-DAB2F952-6571-4EA0-BF4A-CB8ADBD04703Q37239685-136F79EF-361B-4F12-BAB6-75621A553D82Q37267152-32892608-727D-4BDE-9DC1-E43894B2F36DQ37330045-C5A0EA05-7CA6-4BF1-B32C-8BB90A7A31EAQ38194113-5C47A6EA-1826-4C3E-9DDE-EBC9B548EB00Q38349136-0D559FF6-8FEB-43D4-B601-3040366E7EAAQ38835960-B7157640-7BDA-46D7-989B-2AE04DBCB035Q39573995-4904E49B-D163-49DD-A5EF-A730221A6C14Q39759671-3D1953C0-D3F7-4CAF-B4C6-4518627616A8Q41836078-6D2D0133-01A0-4558-AB9A-A3289DB453CCQ41854246-DBABC7AB-A176-4A9C-95B2-E8D517C706D0Q41902903-D301EDB4-BF93-431B-9F5F-D9F44A718B00Q41996394-75D1C3FA-1944-4EE7-A228-2F33ADDCC090Q42742396-2305E729-130D-4D33-8496-8584BD527505Q45220920-D2261346-928B-4464-AC9E-100A98C790D0Q46376547-AF9C20C0-C9F9-424B-A23A-FB01959A62E5Q46609372-74807DD0-8D1C-4CEA-A983-C058F1D24AFCQ50006887-1EB9F1B5-4D21-4B3A-9AF8-D8CC31F02CB3
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
High-density lipoproteins and atherosclerosis.
@ast
High-density lipoproteins and atherosclerosis.
@en
High-density lipoproteins and atherosclerosis.
@nl
type
label
High-density lipoproteins and atherosclerosis.
@ast
High-density lipoproteins and atherosclerosis.
@en
High-density lipoproteins and atherosclerosis.
@nl
prefLabel
High-density lipoproteins and atherosclerosis.
@ast
High-density lipoproteins and atherosclerosis.
@en
High-density lipoproteins and atherosclerosis.
@nl
P1476
High-density lipoproteins and atherosclerosis.
@en
P2093
Daniel J Rader
P304
P356
10.1016/S0002-9149(02)02635-8
P407
P577
2002-10-01T00:00:00Z